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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j idA 27-year-old woman with history of intravenous drug abuse
and AIDS presented with fever and a blistering skin rash on the
dorsum, neck, face, and ear. She reported no prodromal symptoms
prior to the rash and a rapid worsening in the previous 2 days. A
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http://dx.doi.org/10.1016/j.ijid.2012.11.016physical examination revealed the patient to be feverish (axillary
temperature of 38.5 8C) with a painful vesicular rash on the right
scapular girdle, neck, and ear (Figure 1; details of the blisters in
Figure 2). She had no otalgia or signs of meningeal irritation.
Subsequent ﬁndings included a low CD4 cell count (108 cells/mm3)
and an elevated blood plasma HIV-1 RNA concentration (180 000
copies/ml).
The patient was admitted with a diagnosis of herpes zoster with
involvement of vertebral nerves C2 and C3, also known as herpes
zoster occipitocollaris, and started treatment with intravenous
acyclovir, tramadol, and pregabalin. She completed a 14-day
course of the antiviral agent and was discharged with improve-
ment of the herpetic lesions.Figure 2. Detailed view of the blisters.
ternational Society for Infectious Diseases.
E. Oliveira, J. Alexandre / International Journal of Infectious Diseases 17 (2013) e213–e214e214Patients suffering from any condition predisposing to decreased
cell-mediated immunity, like AIDS, cancer, or treatment with
immunosuppressive drugs, are at increased risk for varicella-zoster
virus reactivation and infection, and often have a more exuberant
and severe disease with a greater risk of complications and visceral
dissemination.1
All immunosuppressed zoster patients with the presentation of
a rash within 1 week should undergo prompt antiviral treatment.
This can be with oral agents for localized disease, or with
intravenous acyclovir in those with disseminated infections,
visceral organ involvement, ophthalmic involvement, or severe
immunosuppression.2 Complementary to antiviral drug therapy,appropriate analgesic therapy should be initiated promptly, in
order to reduce the incidence and severity of acute pain and post-
herpetic neuralgia.2
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